News

New brain-haemorrhage treatment tested on patients for the first time

Researchers from Rigshospitalet have launched first-in-human trials of a groundbreaking new treatment principle for brain haemorrhages. The professor behind the trials has been working on this breakthrough for 25 years, and he is now about to embark on the second treatment breakthrough in his career. ​​​

Good results with surgery for malignant pleural mesothelioma

All the malignant pleural mesothelioma operations in Denmark are performed by just a small group of experts. This has led to large improvements in the survival rate for a disease that was untreatable 20 years ago.​

Alzheimer’s Disease: The Identification of 75 Genetic Risk Factors Brings New Insights

Researchers in Europe, the US and Australia have identified 75 regions of the genome that are associated with Alzheimer's disease. Forty-two of these regions are novel, meaning that they have never before been implicated in the disease.​​

Paracetamol can impair men’s ability to make women pregnant

New research has disconcerting news: Large quantities of paracetamol seem to affect the function of sperm cells and possibly men’s ability to make women pregnant.​

Best in the world to detect cancer mutations

The Center for Genomic Medicine has been awarded the gold medal in genetic variant detection from genomic data in cancer diagnostics. The challenge was organised by the American Food and Drug Administration (FDA) and counted participants from throughout the world.

Gene researchers can now explain different types of migraine

The world's largest gene study on migraine describes, for the first time, the genetic differences between migraine with and without aura. The results look promising for developing new medicines, says the Danish co-author.​

BørneRiget to have royal new name

​Rigshospitalet's new hospital for children, young people, expecting mothers and their families will be named after Her Royal Highness Crown Princess Mary. The hospital is to open in four years, and it will be called ‘Mary Elizabeth’s Hospital - Rigshospitalet for Children, Teens and Expecting Families´.

Not all patients with COVID-19 need the same medicine

​Some patients with COVID pneumonia benefit from antibody medicine to combat the virus. For others, this is no help at all - and perhaps it has the opposite effect.

​ Chemicals and fossil fuels could be behind falling birth rates

​Alarming new international study published in the prestigious journal Nature Reviews Endocrinology.

Well-known drug could help the most severely affected Covid-19 patients in intensive-care departments

​Damage to the body's most important organs is reduced significantly in mechanically ventilated patients with corona if they receive a medicine called prostacyclin. This is the result of a new study from Rigshospitalet.
More news

 International KFJ Award

 Meet our researchers

 Ranking